Gilead to Expand Footprint in Oceanside

Oceanside, Calif., March 9, 2022 – Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company has completed the purchase of additional land in Oceanside, California from a joint venture between Lincoln Property Company’s West Coast affiliate, LPC West Inc., and an affiliate of Cerberus Capital Management, L.P. Under the terms of this agreement, Gilead will acquire approximately 27 acres of undeveloped land neighboring Gilead’s existing facility in Oceanside at 4010 Ocean Ranch Boulevard.

“Our Oceanside location focuses on supporting clinical manufacturing and process development for Gilead and Kite,” said Joydeep Ganguly, Senior Vice President, Corporate Operations. “We value the talent and infrastructure available in Southern California and purchased the land to give us the ability to bring more manufacturing operations to the area.”

About Gilead Sciences
Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.

For more information about Gilead, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@Gilead Sciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.